Ricevi le ultime notizie sulle azioni Collegium Pharmaceutical con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di COLL

Ultime notizie per

COLLEGIUM PHARMACEUTICAL INC

Collegium Pharmaceutical

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical Inc

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies Ltd

Colliers International Group Inc. - Subordinate Voting Shares

Colliers International Group Inc

Collective Mining Ltd

COLLECTIVE AUDIENCE INC by Collective Audience, Inc.

Collective Audience Inc

Collaborative Investment Series Trust Rareview Systematic Equity ETF

Collaborative Investment Series Trust Anydrus Advantage ETF

Collaborative Investment Series Trust Rareview Total Return Bond ETF

Collaborative Investment Series Trust Mohr Sector Nav ETF

Collaborative Investment Series Trust Rareview 2x Bull Cryptocurrency & Precious Metals ETF

Collaborative Investment Series Trust Goose Hollow Multi-Strategy Income ETF

Collaborative Investment Series Trust Mohr Company Nav ETF

Collab Z Inc

Collaborative Investment Series Trust MOHR IND NAV ETF

COLLECTIVE METALS INC by COLLECTIVE METALS INC.

Collective Metals Inc

Collective Mining Ltd Ordinary Shares

COLLINS FOODS LTD NWMKT by Collins Foods Ltd Newmarket Qld

Collins Foods Ltd

Earnings

Press Releases

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

General

Collegium Announces $25 Million Accelerated Share Repurchase Program

News

Collegium to Participate in Upcoming Investor Conferences

Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030

Investing in Innovation: Four Small-Caps Driving the Future of Pain Therapy

Collegium Announces $150 Million Share Repurchase Program

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

AQST

ASRT

COLL

NTRB

NTRBW

TEVA

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Arvinas

ATAI Life Sciences

Cormedix

Cronos Group

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

GH Research

Innoviva

Maze Therapeutics

MBX Biosciences

Mind Medicine (MindMed) Inc. - Common Shares

Mind Medicine

Nektar Therapeutics

Nuvation Bio

Oculis Holding

Pacira BioSciences

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

Septerna

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharma

Trevi Therapeutics

Wave Life Sciences Ltd. - Ordinary Shares

WAVE Life Sciences

Xeris Biopharma Holdings, Inc. - Common Stock

Comments

Collegium Pharmaceutical Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO